Cargando…
Femara(®) and the future: tailoring treatment and combination therapies with Femara
Long-term estrogen deprivation treatment for breast cancer can, in some patients, lead to the activation of alternate cellular pathways, resulting in the re-emergence of the disease. This is a distressing scenario for oncologists and patients, but recent intensive molecular and biochemical studies a...
| Autores principales: | , |
|---|---|
| Formato: | Texto |
| Lenguaje: | English |
| Publicado: |
Springer US
2007
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2001220/ https://www.ncbi.nlm.nih.gov/pubmed/17912640 http://dx.doi.org/10.1007/s10549-007-9697-2 |